Amanda Twede Crawford is recorded as CFO at Owlet, Inc. (OWLT). Owlet, Inc. reported in an 8-K filed July 9, 2024 that Amanda Twede Crawford was appointed Chief Financial Officer and principal financial officer and principal accounting officer, effective July 9, 2024. The proxy statement of Owlet, Inc. reports total compensation of $2,415,456 for Amanda Twede Crawford in fiscal 2025, including a base salary of $340,962. Disclosed compensation is on record for 2 fiscal years. Amanda Twede Crawford has spoken on 9 earnings calls and 2 other investor events across 1 company, most recently for Owlet, Inc. on August 11, 2026. Owlet, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Owlet, Inc. includes Jonathan Harris (CEO), Kurt Workman (CEO, Chairman and Board Member), Lior Susan (Chairman and Board Member) and 7 others.
“On July 8, 2024, the Board of Directors (the "Board") of the Company appointed Amanda Twede Crawford, the Company's current Vice President, Financial Planning and Analysis, to serve as the Company's Chief Financial Officer and principal financial officer and principal accounting officer, effective July 9, 2024, to succeed Kathryn Scolnick in these positions.”
“Turning to our second quarter 2026 financial performance on slide 11. Unless noted otherwise, I will be comparing Q2 2026 to the results of Q2 2025. Q2 total revenue was a record of $33.9 million, up 29.9% year over year.”
“So right now in the US, it's about 11% penetration rate of births, which some of our markets are over 20%. So we see a big difference between key markets. And one of the biggest things that we've been working on is like AI search optimization, which is really critical.”
“Turning to our first quarter 2026 financial performance on slide 11. Unless noted otherwise, I will be comparing first quarter 2026 results to the first quarter of 2025.”
“I also want to thank our employees for another successful quarter and for the terrific execution that delivered our record 2025 performance. I'll begin on slide 12.”
Chief Financial Officer Amounts shown represent the aggregate grant date fair value for financial statement reporting purposes of restricted stock units (“RSUs”) awards and performance-based restricted stock units (“PRSUs”) as computed in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification Topic 718 ("FASB ASC Topic 718"). See Note 10 (Share-Based Compensation) to the Company’s consolidated financial statements included in the Form 10-K for the assumptions used in determining these values. Our named executive officers, other than Mr. Workman, received time-based RSUs, the grant date fair value of which was based on the fair value of our Class A common stock on the date of grant. In addition, our named executive officers, other than Mr. Workman, also received PRSUs which are eligible to be earned, if at all, based on achievement of cumulative net revenue goals depending on the Company's performance during the period from January 1, 2025 to December 31, 2028, and the fair value of these awards was based on the grant date fair market value of our Class A common stock. The shares are eligible to be earned on a quarterly basis during the performance period depending on the results of the cumulative net revenue. The grant date fair value of $2,990,000 and $1,495,000 for the PRSUs awarded to Mr. Harris and Ms. Crawford, respectively, is based on the probable outcome (which reflects full 100% vesting of the awards). Accordingly, the probable outcome of the performance conditions as of the grant date, are the same as the maximum level of performance under the performance conditions as of the grant date. For 2025, amounts represent, for Mr. Workman, $1,654 in Company-paid contributions to a healthcare savings account and for Ms. Crawford, $2,150 in Company-paid contribution to a healthcare savings account and $13,092.30 in Company-matching 401K contributions. Effective October 1, 2025, Mr. Workman transitioned into a non-employee director role, Executive Chairman of the Board. For the remainder of 2025, he received a pro-rated portion of the Executive Chair retainer fee of $200,000 and an annual equity award pursuant to our non-employee director compensation program. The following table sets forth the aggregate dollar amount of all fees paid to Mr. Workman during 2025 for his services as a non-employee director: Name Fees Earned or Paid in Cash ($) Stock Awards ($) Total ($) Kurt Workman 50,000 217,829(a) 267,829(a) (a) Mr. Harris ceased serving as our President and Chief Executive Officer on April 6, 2026. Ms. Crawford elected to receive her entire 2025 annual incentive cash bonus in the form of fully vested shares of our Class A common stock.
Chief Financial Officer Amounts shown represent the aggregate grant date fair value for financial statement reporting purposes of restricted stock units (“RSUs”) awards and performance-based restricted stock units (“PRSUs”) as computed in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification Topic 718 ("FASB ASC Topic 718"). See Note 10 (Share-Based Compensation) to the Company’s consolidated financial statements included in the Form 10-K for the assumptions used in determining these values. Our named executive officers, other than Mr. Workman, received time-based RSUs, the grant date fair value of which was based on the fair value of our Class A common stock on the date of grant. In addition, our named executive officers, other than Mr. Workman, also received PRSUs which are eligible to be earned, if at all, based on achievement of cumulative net revenue goals depending on the Company's performance during the period from January 1, 2025 to December 31, 2028, and the fair value of these awards was based on the grant date fair market value of our Class A common stock. The shares are eligible to be earned on a quarterly basis during the performance period depending on the results of the cumulative net revenue. The grant date fair value of $2,990,000 and $1,495,000 for the PRSUs awarded to Mr. Harris and Ms. Crawford, respectively, is based on the probable outcome (which reflects full 100% vesting of the awards). Accordingly, the probable outcome of the performance conditions as of the grant date, are the same as the maximum level of performance under the performance conditions as of the grant date. For 2025, amounts represent, for Mr. Workman, $1,654 in Company-paid contributions to a healthcare savings account and for Ms. Crawford, $2,150 in Company-paid contribution to a healthcare savings account and $13,092.30 in Company-matching 401K contributions. Effective October 1, 2025, Mr. Workman transitioned into a non-employee director role, Executive Chairman of the Board. For the remainder of 2025, he received a pro-rated portion of the Executive Chair retainer fee of $200,000 and an annual equity award pursuant to our non-employee director compensation program. The following table sets forth the aggregate dollar amount of all fees paid to Mr. Workman during 2025 for his services as a non-employee director: Name Fees Earned or Paid in Cash ($) Stock Awards ($) Total ($) Kurt Workman 50,000 217,829(a) 267,829(a) (a) Mr. Harris ceased serving as our President and Chief Executive Officer on April 6, 2026. Ms. Crawford elected to receive her entire 2025 annual incentive cash bonus in the form of fully vested shares of our Class A common stock.
